ViroPharma to Present at Two Upcoming Healthcare Conferences

EXTON, Pa., June 3 ViroPharma Incorporated(Nasdaq: VPHM) today announced that Vincent Milano, president and chiefexecutive officer of ViroPharma, will present at the Goldman Sachs 29th AnnualGlobal Healthcare Conference at 4:00 P.M. PDT on Tuesday, June 10, 2008. Theconference is being held at the Ritz-Carlton, Laguna Nigel in Dana Point, CA.

ViroPharma also announced that William Roberts, vice president, corporatecommunications of ViroPharma, will present at the Needham Seventh AnnualBiotechnology and Medical Technology Conference at 8:00 A.M. EDT on Wednesday,June 11, 2008. The conference is being held at the New York Palace Hotel.

ViroPharma's presentations will be webcast live for investors throughhttp://www.viropharma.com and available for a period of 14 days following theconferences.

About ViroPharma Incorporated

ViroPharma Incorporated is a biopharmaceutical company dedicated to thedevelopment and commercialization of products that address serious diseasestreated by physician specialists and in hospital settings. ViroPharmacommercializes Vancocin(R), approved for oral administration for treatment ofantibiotic-associated pseudomembranous colitis caused by Clostridium difficileand enterocolitis caused by Staphylococcus aureus, includingmethicillin-resistant strains (for prescribing information, please downloadthe package insert at http://www.viropharma.com/Products.aspx). ViroPharmacurrently focuses its drug development activities in diseases includingcytomegalovirus (CMV) and Clostridium difficile. For more information onViroPharma, visit the company's website at http://www.viropharma.com.

SOURCE ViroPharma Incorporated

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...